Hydroxychloroquine- and Azithromycin-Induced Transient Left-Bundle Branch Block in a Patient with COVID-19
Since the emergence of the novel coronavirus (referred to as severe acute respiratory syndrome coronavirus 2 [SARS-Cov-2]) in December 2019 in Wuhan City, China, and up until now, several studies and trials have been conducted to manage infected patients…